Indication

Vancomycin resistant Enterococcus faecium bacteremia

Vancomycin-resistant *Enterococcus faecium* bacteremia is a serious bloodstream infection caused by strains of the Gram-positive bacterium *Enterococcus faecium* that have acquired resistance to glycopeptide antibiotics, most notably via *vanA* or *vanB* gene clusters that alter cell-wall peptidoglycan precursors. Read more about Vancomycin resistant Enterococcus faecium bacteremia

53 drugs 36 manufacturers

Advertisement

Drugs that treat it

Common Vancomycin resistant Enterococcus faecium bacteremia therapies.

Showing 10–18 of 53 drugs

LINEZOLID

VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM INFECTION·+11
Mylan Pharmaceuticals

LINEZOLID

OXAZOLIDINEDIONES·VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM INFECTION·+11
Major Pharamceuticals

LINEZOLID

OXAZOLIDINEDIONES·VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM INFECTION·+11
CAMBER PHARMACE

LINEZOLID

OXAZOLIDINEDIONES·VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM INFECTION·+11
GREENSTONE LLC.

LINEZOLID

OXAZOLIDINEDIONES·VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM INFECTION·+11
ASCEND LABORATO

LINEZOLID

VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM INFECTION·+11
Amneal Pharmaceuticals

LINEZOLID

VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM INFECTION·+11
MYLAN INSTITUTI

LINEZOLID

VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM INFECTION·+11
AVPAK

LINEZOLID

OXAZOLIDINEDIONES·VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM INFECTION·+11
ALEMBIC PHARMAC
Filter & compare in the drug finder →Opens the drug finder with Vancomycin resistant Enterococcus faecium bacteremia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Vancomycin resistant Enterococcus faecium bacteremia.

Vancomycin-resistant *Enterococcus faecium* bacteremia is a serious bloodstream infection caused by strains of the Gram-positive bacterium *Enterococcus faecium* that have acquired resistance to glycopeptide antibiotics, most notably via *vanA* or *vanB* gene clusters that alter cell-wall peptidoglycan precursors.

Predominantly a healthcare-associated infection, it typically affects hospitalized, severely ill, or immunocompromised individuals, including patients with indwelling central venous catheters, prolonged broad-spectrum antibiotic exposure, or recent abdominal surgery.

Pathophysiologically, colonized bacteria translocate across compromised mucosal barriers or enter through intravascular devices directly into the systemic circulation, triggering systemic inflammatory manifestations such as fever, tachycardia, hemodynamic instability, and potentially lethal sepsis.

Personalize your experience

Follow Vancomycin resistant Enterococcus faecium bacteremia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it